{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR002959",
      "entity_text" : "TNFalpha",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2244",
      "entity_text" : "Aspirin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Aspirin and etanercept are inhibitors of TNFalpha and each can reduce ICAM-1 levels, diabetes related leukostasis, and BRB breakdown in diabetic rats without altering VEGF levels, showing that TNFalpha is involved in this process and that it operates through a distinct pathway from VEGF.",
  "reading_complete" : "2020-07-28T14:17:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:15:43Z",
  "trigger" : "are inhibitors",
  "evidence" : [ "Aspirin and etanercept are inhibitors of TNFalpha" ],
  "pmc_id" : "7150236",
  "score" : 0
}